Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Department of Health and Human Services
Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory of the illness remain poorly understood. The purpose of this initiative is to advance translational research to better understand the emergence and trajectory of schizophrenia and related disorders in mid to late life, and to identity targets for future development of prevention and treatment efforts.
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Next 90 days
Posted
11/18/2024
Closes
2026-09-07
Eligibility
Eligibility
Private institutions of higher educationSmall businessesCounty governmentsPublic and State controlled institutions of higher educationFor profit organizations other than small businessesSpecial district governmentsCity or township governmentsNative American tribal governments (Federally recognized)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNative American tribal organizations (other than Federally recognized tribal governments)State governmentsOthers (see text field entitled "Additional Information on Eligibility" for clarification)Public housing authorities/Indian housing authoritiesIndependent school districtsNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Program
Funding area
Health - HL
Opportunity #
PAR-25-040
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov